[PDF][PDF] Adipose tissue metabolism and cardiometabolic health in obesity: effects of pharmacological and lifestyle interventions

RME Stinkens - 2017 - cris.maastrichtuniversity.nl
The worldwide prevalence of obesity has increased enormously over the last decades and
numbers are still increasing every year. According to the World Health Organization, 13% of …

Obesity and Cardiovascular Disease

E Obeng-Gyimah, F Sam - Adipose Tissue and Adipokines in Health and …, 2014 - Springer
Cardiovascular disease is the number one killer in the world, and obesity is a leading
modifiable risk factor of cardiovascular disease. More than one-third of US adults (35.7%) …

Adipose biology, cardiovascular, and cardiometabolic disease: novel insights and new targets for intervention

AF El-Yazbi, GY Oudit - Clinical Science, 2020 - portlandpress.com
Adipose biology research has grown rapidly offering new insights into the physiological and
pathophysiological roles of different body fat depots. This Thematic Collection of Clinical …

Obesity and cardiovascular disease: pathophysiology, related diseases and effect of weight loss

A Pathak, M Galinier, JM Senard - MT Cardio, 2007 - jle.com
Obesity is becoming a global epidemic in both children and adults. This growing epidemy is
now also affecting countries from the third world. Obesity is directly increasing morbidity and …

Type 2 diabetes and cardiovascular disease: getting to the fat of the matter

KB Goralski, CJ Sinal - Canadian journal of physiology and …, 2007 - cdnsciencepub.com
The increasing national prevalence of obesity is a major public health concern and a
substantial burden on the health care resources of Canada. In addition to the direct health …

Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?

H Bays, L Blonde, R Rosenson - Expert review of cardiovascular …, 2006 - Taylor & Francis
An increase in bodyweight is generally associated with an increased risk of excessive fat-
related metabolic diseases (EFRMD), including Type 2 diabetes mellitus, hypertension and …

Cardiometabolic risk factors and their treatment in patients with Type 2 diabetes

S Kumar - Expert review of endocrinology & metabolism, 2007 - Taylor & Francis
The prevalence of obesity-associated diabetes is increasing dramatically in the UK and
worldwide. Obesity, particularly abdominal obesity, is not only associated with other …

[PDF][PDF] New vistas for the treatment of obesity: turning the tide against the leading cause of morbidity and cardiovascular mortality in the developed world

NE Leporn, DD Fouchian… - Reviews in …, 1900 - venus-pro-bucket.s3.amazonaws …
Excess adiposity and obesity are the root cause of at least 27 diseases that cause
considerable lifelong morbidity and, in many scenarios, eventual cardiovascular mortality …

Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk

JP Després - Heart, 2009 - heart.bmj.com
WHAT IS OBESITY? Almost every week there is an article published in a major national
newspaper on the epidemic proportions reached by obesity in various countries. The …

The pathophysiology of visceral adipose tissues in cardiometabolic diseases

MJ Lee, J Kim - Biochemical Pharmacology, 2024 - Elsevier
Central pattern of fat distribution, especially fat accumulation within the intraabdominal cavity
increases risks for cardiometabolic diseases. Portal hypothesis combined with a …